Predictive Value of pCLE Findings in Pediatric IBD

NCT02003859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2014-11-19

No results posted yet for this study

Summary

Studies over the past two decades have convincingly demonstrated the role of barrier dysfunction in the pathogenesis of inflammatory bowel disease. It previously shown that optical biopsy with probe-based confocal laser endomicroscopy (pCLE) could be used to assess mucosal barrier function. Furthermore, mucosal barrier dysfunction on pCLE was shown to be predictive of disease relapse in adult IBD patients. The purpose of the current study is to determine the predictive value of pCLE findings in pediatric IBD patients.

Conditions

Sponsors & Collaborators

  • University of Alberta

    collaborator OTHER
  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER
  • Scientific Center of Children's Health RAMS

    lead OTHER

Principal Investigators

  • Andrey A Shavrov, M.D. · The Scientififc Center of Children's Health

Eligibility

Min Age
10 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02003859 on ClinicalTrials.gov